Clinical Trial

Subclinical Primary Aldosteronism in Diabetes At-Risk for Kidney Disease

Name: Subclinical Primary Aldosteronism in Diabetes At-Risk for Kidney Disease — clinical trial record (NCT06190158)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: SubPA-DKD

Active, Not Recruiting Early Phase 1

View on ClinicalTrials.gov →

Summary

The aim of this protocol is to assess the presence and severity of primary aldosteronism pathophysiology in patients with type 2 diabetes who have, or are at-risk for developing, chronic kidney disease.

Protocol Amendment History 1 change

critical Enrollment closed, study ongoing 2026-08-14

Trial Details

NCT Number	NCT06190158
Lead Sponsor	Brigham and Women's Hospital
Conditions	Type 2 Diabetes, Chronic Kidney Diseases
Enrollment	125 participants
Start Date	2024-05-15
Primary Completion	2029-07-31 (estimated)
Study Completion	2029-07-31 (estimated)
Updated on ClinicalTrials.gov	2026-08-13